Navidea Biopharmaceuticals (NAVB) Stock: Skyrocketing on LOI News

By |September 6th, 2016|

Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB)

Navidea Biopharmaceuticals is having an incredible day in the market today, and for good reason. The company announced that it has excecuted a key Letter of Intent that will drive a strong amount of revenue into the company. Today, we’ll talk about the news, what we saw from the stock […]